RESOTHER PHARMA
ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on developing peptide-based drugs derived from the endogenous immunomodulator Annexin A1 as resolution therapy for diseases where neutrophil-driven inflammation plays a key pathological role. Their current focus is on cardiovascular disorders and inflammatory disorders with a large unmet medical need.
RESOTHER PHARMA
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2016-01-01
Address:
Holte, Syddanmark, Denmark
Country:
Denmark
Website Url:
http://www.resotherpharma.com
Total Employee:
1+
Status:
Active
Contact:
+ 45 41 88 95 70
Email Addresses:
[email protected]
Total Funding:
2.37 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Neomorph
Neomorph is a biotechnology company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Strakan Group
Strakan Group is a private Scottish specialty drugmaker
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
CAPNOVA
CAPNOVA investment in Venture Round - ResoTher Pharma
M Ventures
M Ventures investment in Seed Round - ResoTher Pharma
CAPNOVA
CAPNOVA investment in Seed Round - ResoTher Pharma
Official Site Inspections
http://www.resotherpharma.com
- Host name: linux2.curanet.dk
- IP address: 94.231.106.223
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
More informations about "ResoTher Pharma"
Home - ResoTher Pharma
ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on discovering and developing peptide-based drugs as for diseases …See details»
About - ResoTher Pharma
ResoTher Pharma is a clinical stage biotechnology company located in Copenhagen, Denmark. We are on a mission to deliver new and effective treatment options for patients suffering from cardiovascular disease.See details»
Board of Directors - ResoTher Pharma
Mr. Øvlesen is co-founder and presently serves as CEO of SynAct Pharma, which is listed on Nasdaq Stockholm. Henrik Stage has held roles such as VP, CFO, and CEO in a number of successful international corporations, including …See details»
ResoTher Pharma - Crunchbase Company Profile & Funding
ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on developing peptide-based drugs derived from the endogenous …See details»
ResoTher Pharma - LinkedIn
ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation.See details»
ResoTher Pharma - Pharmaceutical Companies Database - ICH GCP
ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on developing peptide-based drugs derived from the endogenous …See details»
ResoTher Pharma ApS - VentureRadar
"ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on developing peptide-based drugs derived from the endogenous …See details»
ResoTher Pharma's financial review - Apollo.io
View ResoTher Pharma (http://www.resotherpharma.com) location in Capital Region of Denmark, Denmark, revenue, competitors and contact information. Find and reach ResoTher Pharma's …See details»
Management - ResoTher Pharma
Thomas Jørgensen has more than 30 years of experience working within the global pharmaceutical industry with clinical and pre-clinical program management, alliance management and CMC development for a variety of therapeutic …See details»
ResoTher Pharma - Craft
ResoTher Pharma is a biotechnology company developing therapies for cardiovascular and inflammatory disorders. It is focused on designing peptide-based drugs derived from the …See details»
ResoTher Pharma - Products, Competitors, Financials, Employees ...
ResoTher Pharma is a clinical stage biotechnology company with a focus on cardiovascular disease. Use the CB Insights Platform to explore ResoTher Pharma's full profile.See details»
ResoTher Pharma | DANISH BIO - Dansk Biotek
ResoTher Pharma is a clinical stage biotechnology company focused on developing novel peptide therapeutics for resolution of inflammation. At Dansk Biotek we use cookies for analytical …See details»
ResoTher Pharma - PitchBook
ResoTher Pharma is headquartered in Holte, Denmark. What is the size of ResoTher Pharma? ResoTher Pharma has 10 total employees. What industry is ResoTher Pharma in? ResoTher …See details»
ResoTher Pharma receives a €2.5 million grant from European …
HOLTE, Denmark, Nov. 6, 2023 /PRNewswire/ -- ResoTher Pharma, a biotech company focused on developing life-saving options for patients suffering from cardiovascular disease, today …See details»
Research - ResoTher Pharma
At ResoTher Pharma, we focus on endogenous immune regulatory pathways in the propagation and resolution of inflammation. We work to validate a class of novel therapeutic peptides in …See details»
ResoTher Pharma Company Information - Funding, Investors, and …
Https://resotherpharma.com. ResoTher Pharma is a privately held biotechnology company. Get the top 10 companies of the week in your email, every Tuesday. Subscribe. OR DOWNLOAD …See details»
ResoTher Pharma strengthens its leadership team
Aug 2, 2021 · ResoTher Pharma is pleased to announce the following changes to its leadership team to further support the growth and development of the company. Teis Vester, MSc., will …See details»
Jay Bhattacharya picked by Trump to lead NIH : Shots - NPR
1 day ago · Dr. Jay Bhattacharya, a Stanford health researcher, is in line to lead the National Institutes of Health. Early in the pandemic he argued against lockdowns and focusing on …See details»
ResoTher Pharma ApS - VentureRadar
Website: https://resotherpharma.com/ Develops peptide-based drugs derived from Annexin A1 for resolution therapy in cardiovascular and inflammatory disorders with unmet medical needs. …See details»
Press Releases - ResoTher Pharma
Sep 17, 2024 · We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use …See details»